ALBERT MA: Open Payments
NPI 1275596496 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 48 payments from 10 companies in 2025. Trend: 2023 $642 · 2024 $573 · 2025 $1,283
Food & beverage: $1,173Education: $109
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 22 | $501 |
| Teva Pharmaceuticals USA, Inc. | 6 | $325 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Supernus Pharmaceuticals, Inc. | 5 | $78 |
| Neuronetics, Inc. | 1 | $74 |
| Lundbeck LLC | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Globus Medical, Inc. | 1 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: ARISTADA, UZEDY, LYBALVI, ABILIFY ASIMTUFII, Qelbree, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, COBENFY.
Industry payments across CA — which companies pay providers there.
